St. Jude medical devices after the Abbott acquisition and what to check in 2026
What the St. Jude name means now
St. Jude medical devices remain a common search term because hospitals, clinicians, procurement teams, and patients still see the legacy brand on implant cards, programmers, remote monitors, electrophysiology catheters, product manuals, and FDA records. The main point is straightforward: St. Jude Medical is no longer an independent public company. Abbott completed its acquisition of St. Jude Medical on January 4, 2017, and St. Jude Medical became a wholly owned Abbott subsidiary. Since then, many product lines have continued under Abbott or Abbott Medical naming, while older documentation, implanted devices, and regulatory records may still use St. Jude Medical, SJM, Pacesetter, Merlin, or related legacy names.
For readers comparing diagnostic devices, this creates a practical verification issue. A product may now be clinically associated with Abbott, while the device label, FDA database entry, or hospital inventory system still refers to St. Jude Medical. For that reason, checks should start with the model number, UDI, lot number, software version, implant date, and the responsible manufacturer or recalling firm, not only the brand name printed on a document. You can also explore more in Diagnostic Devices.
For more coverage of connected monitoring and diagnostic technology, see the Diagnostic Devices section.
Device areas historically linked to St. Jude Medical
Before the Abbott acquisition, St. Jude Medical was known primarily for cardiovascular and neuromodulation technologies. Its portfolio was not limited to one device type. Public company filings before the transaction described major categories including cardiac rhythm management, atrial fibrillation products, cardiovascular products, heart failure technologies, structural heart products, and neuromodulation. That history matters because the St. Jude name can appear on both implantable therapeutic devices and products that generate diagnostic or monitoring data.
| Area | Examples associated with the St. Jude legacy | Why it matters for diagnostic review |
|---|---|---|
| Cardiac rhythm management | Pacemakers, ICDs, CRT-P and CRT-D systems, leads, programmers, home transmitters | These devices record rhythm episodes, battery status, device settings, and therapy history used in clinical follow-up. |
| Electrophysiology | Diagnostic EP catheters, mapping systems, introducers, ablation-related technologies | EP tools support mapping, stimulation, and recording during arrhythmia procedures. |
| Heart failure monitoring | CardioMEMS HF system and pulmonary artery pressure monitoring workflows | Hemodynamic data can help physicians manage selected heart failure patients. |
| Cardiovascular and structural heart | Vascular closure, pressure measurement, OCT imaging, valve and structural heart technologies | Some products support procedural imaging, measurement, or post-procedure management. |
| Neuromodulation | Spinal cord stimulation, dorsal root ganglion stimulation, deep brain stimulation-related products | These are not diagnostic devices in the narrow sense, but they may appear in broader searches for St. Jude Medical devices. |
Abbott’s current cardiovascular portfolio still includes categories that overlap with the former St. Jude footprint, including cardiac rhythm management, connectivity and remote care, insertable cardiac monitors, electrophysiology diagnostic catheters, imaging and diagnostic systems, mapping systems, and pulmonary pressure monitors. Commercial availability depends on the country, approved indication, and current labeling.
Diagnostic and connected technologies readers should recognize
Search interest in St. Jude Medical devices often comes from people trying to identify a device after a procedure, or from hospitals reconciling older inventory and records. The most relevant diagnostic and connected technologies fall into several groups.
Merlin.net and Merlin@home
Merlin.net is Abbott’s patient care network for remote follow-up of compatible implanted cardiac devices. The related Merlin@home transmitter is a bedside home monitor used after implantation to send device information to a clinic without an in-person visit. Abbott patient materials describe the transmitter as collecting information such as device model and serial number, device settings, event history, and battery status. Some transmitter models can send scheduled automatic transmissions, while others require manual operation.
This is diagnostic in a workflow sense rather than a stand-alone diagnosis. The transmitter does not replace a clinician. It helps move implanted-device data from the patient environment to the clinical team, where trained staff review battery status, recorded episodes, alerts, and device operation.
Insertable cardiac monitors
Abbott’s current remote monitoring materials also reference insertable cardiac monitors that transmit data through mobile applications and Merlin.net services. These small implanted monitors are used to detect or track heart rhythm events over time. For anyone seeing older St. Jude or SJM references, the important step is to identify the exact monitor family, app, and service terms listed on the implant card or patient documentation.
Electrophysiology diagnostic catheters and mapping systems
St. Jude Medical was also associated with electrophysiology products used in arrhythmia procedures, including diagnostic catheters, mapping, navigation, and recording systems. The FDA describes electrophysiology diagnostic catheters as devices intended for EP mapping, stimulation, and recording of cardiac arrhythmias from endocardial and intravascular sites. In practice, these technologies help clinicians locate electrical signals in the heart during diagnostic and interventional procedures.
CardioMEMS HF system
The CardioMEMS HF system is another example where monitoring and disease management overlap. FDA premarket approval records show the system was approved in 2014 for wireless measurement and monitoring of pulmonary artery pressure and heart rate in certain New York Heart Association Class III heart failure patients who had been hospitalized for heart failure in the prior year. FDA records also note that the hemodynamic data are used by physicians for heart failure management with the goal of reducing heart failure hospitalizations. Because labeling can change through supplements, readers should verify the current indication for the exact device and region.
Safety, recall, and cybersecurity context in 2026
The St. Jude name appears in safety records for two different reasons. First, older devices and systems were made or distributed under St. Jude Medical before Abbott acquired the company. Second, some recalls involve reprocessed devices originally made by St. Jude or Abbott, while the recalling firm may be a separate reprocessor or distributor. Mixing up those situations can lead to inaccurate conclusions.
| Date | Event | Why it matters |
|---|---|---|
| October 2016 | St. Jude Medical initiated a recall involving certain Fortify, Unify, and Assura ICD and CRT-D devices due to premature battery depletion concerns. | Battery and implantable-device recalls depend on exact model and serial information, not only the family name. |
| January 4, 2017 | Abbott completed the acquisition of St. Jude Medical. | Later records may refer to Abbott, Abbott Medical, St. Jude Medical, or former St. Jude Medical devices. |
| 2017 to 2018 | FDA cybersecurity communications discussed vulnerabilities and firmware updates involving Abbott, formerly St. Jude Medical, implantable cardiac devices and Merlin@home systems. | Connected devices require attention to firmware, clinic programming, network security, and manufacturer advisories. |
| July 8, 2020 | The FDA recall database lists the Merlin@home cybersecurity-related Class II recall as terminated. | Historical recalls may no longer be active, but they remain relevant when evaluating older documentation. |
| March 5, 2026 | The FDA classified a Medline recall of certain reprocessed electrophysiology and ultrasound catheters as Class I and listed affected products that included St. Jude Medical Response and Supreme diagnostic EP catheters. | This was about certain reprocessed lots and residual particulates; users must check affected item and lot numbers. |
| September 2, 2026 | The FDA updated the Medline recall communication to add lot numbers to the affected product list. | Recall scope can change, so inventory checks should use the latest FDA notice and the manufacturer communication. |
The 2026 Medline recall is especially important for diagnostic device readers because the affected product list included St. Jude Medical Response Diagnostic Electrophysiology Catheter, St. Jude Medical Supreme Diagnostic Electrophysiology Catheter, and St. Jude ViewFlex Ultrasound Catheter among other reprocessed devices. FDA communications stated that the affected reprocessed catheters could contain small residual particulates and that use could pose risks including inflammatory response, systemic infection, granulomatous reaction, thrombus formation, cerebral or pulmonary embolism, or deep vein thrombosis. The recall was classified as the most serious type, but the public FDA communication also stated that, as of May 18, 2026, Medline had not reported serious injuries or deaths associated with the issue.
The takeaway is not that every St. Jude-labeled catheter is affected. The correct interpretation is narrower: specific reprocessed items and lots in the Medline recall required quarantine and destruction or return according to the applicable customer letter. Facilities should not rely on a brand-level search alone. See also: clinical equipment.
How to verify a St. Jude or Abbott device
Anyone reviewing a legacy St. Jude device should start with identifiers. A device name is useful, but it is rarely enough for clinical, regulatory, or purchasing decisions. The same family name can cover multiple models, software versions, lead combinations, lot numbers, and geographic labels.
- Check the patient implant card, device label, packaging, or electronic inventory record for the model number, serial number, UDI, lot number, and implant date.
- Confirm whether the device is labeled St. Jude Medical, Abbott, Abbott Medical, Pacesetter, CardioMEMS, or another affiliated name.
- For implantable cardiac devices, ask the managing clinic which programmer, remote monitor, app, or Merlin.net workflow applies.
- For catheters and other single-use or reprocessed devices, match the item number and lot number against the latest recall or customer notice.
- For connected devices, confirm whether firmware updates, transmitter setup, and clinic enrollment are current.
- For procurement, keep a documented crosswalk between legacy St. Jude names and current Abbott ordering or support names.
Patients should not interpret device function, stop remote monitoring, or change therapy based only on an online article. Device status and treatment decisions should be reviewed with the implanting physician, electrophysiology clinic, heart failure clinic, or the appropriate manufacturer support channel.
What this means for hospitals and buyers
For hospitals, the St. Jude name is mainly a data quality and lifecycle-management issue. Legacy branding can appear in purchasing systems, recall systems, consignment inventory, procedure logs, implant registries, and cybersecurity inventories. If those records are not standardized, a recall search may miss affected items or return too many irrelevant matches.
A practical approach is to separate devices into three groups. The first group includes implanted systems that remain under clinical follow-up, such as pacemakers, ICDs, CRT devices, insertable monitors, and CardioMEMS sensors. These require patient-specific management, clinic oversight, and accurate device identification. The second group includes procedural diagnostic tools such as EP catheters and mapping-related accessories. These require inventory control, lot-level recall screening, and attention to whether the item is an original manufacturer product or a reprocessed product. The third group includes connected infrastructure, such as home transmitters, programmers, apps, and web-based follow-up networks. These require cybersecurity, software, access-control, and service-continuity review.
For buyers comparing diagnostic technologies, the Abbott acquisition also means that a current catalog search may not match an older product name. A request for St. Jude devices should be translated into the precise clinical use case: rhythm monitoring, remote follow-up, EP mapping, pulmonary artery pressure monitoring, intravascular imaging, or another function. That reduces the risk of selecting the wrong product family or missing an updated version.
Frequently asked questions
Is St. Jude Medical the same as Abbott?
St. Jude Medical became part of Abbott after the acquisition completed on January 4, 2017. In current practice, many former St. Jude product lines and support pathways sit within Abbott or Abbott Medical. However, older labels, manuals, implant cards, and FDA records may still use St. Jude Medical or related legacy names.
Are St. Jude medical devices still in use?
Yes. Many implanted cardiac devices have multi-year service lives, and older devices may remain under routine clinical follow-up. Hospitals may also encounter legacy names in documentation, historical procedure records, and regulatory databases. Whether a specific device is still supported or appropriate for use depends on the exact model, indication, and safety status.
Are all St. Jude diagnostic catheters affected by the 2026 recall?
No. The 2026 FDA communications discussed specific Medline ReNewal reprocessed electrophysiology and ultrasound catheters, including certain St. Jude Medical Response and Supreme diagnostic EP catheter items. The action depended on item and lot numbers. Facilities should check their inventory against the latest FDA and manufacturer recall documentation before deciding whether a product is affected.
What should a patient do if their implant card says St. Jude Medical?
The patient should keep the implant card and contact the managing clinic if they have questions. The clinic can identify the device through the model and serial number, confirm whether remote monitoring is active, and advise whether any advisory, firmware update, or follow-up action applies. Patients should not stop using a monitor or change treatment without clinician guidance.
Why do FDA records sometimes say Abbott formerly St. Jude Medical?
Regulatory records often preserve the historical manufacturer name while also identifying the current corporate owner or successor. The phrase helps readers connect older St. Jude products with Abbott oversight after the 2017 acquisition. For accurate verification, use the record’s model, PMA or 510(k) number, recall number, UDI, lot number, and dates.
